
TekCyte
TekCyte is a world leader in the development and manufacture of advanced coatings for medical device and biomedical applications.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
investor | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
AUD30.0k | Grant | ||
Total Funding | 000k |
Related Content
TekCyte is a global leader in the development and manufacture of advanced coatings for medical devices and biomedical applications. The company specializes in creating ultrathin, highly stable, and low-toxicity coatings that significantly enhance the performance and safety of medical devices. TekCyte serves medical device manufacturers worldwide, offering scalable manufacturing processes that can handle large volumes of devices. The company's core business model revolves around providing high-quality, cost-effective coating solutions, making money through partnerships and direct sales to medical device companies. TekCyte's advanced hyperbranched polyglycerol coatings are suitable for a wide range of metal and polymer materials, ensuring versatility and broad applicability in the biomedical field. The company operates in the medical device and biomedical markets, focusing on innovation and efficiency to meet the evolving needs of its clients.
Keywords: biomedical coatings, medical devices, scalable manufacturing, low toxicity, hyperbranched polyglycerol, performance enhancement, safety, cost-effective, global leader, advanced technology.